Survey: Illinois seniors delay buying prescription drugs

Some seniors in Illinois are delaying buying prescription drugs because of the cost, according to the AARP. United Press International reports: "Twenty-one percent of AARP members surveyed in Illinois report not filling or delaying filling prescriptions due to cost, a survey indicated.

Nearly one in five said they had to cut back on food and utilities to afford needed medications, the AARP survey of Illinois residents 50 and over indicated. The survey found 63 percent are concerned about affordability of their prescription drugs. Eighteen percent reported they took less than the prescribed amount to make the medicine last longer.

The survey found women and Hispanics say they tend to be harder hit than the general 50-plus population by high drug costs. In the past year, prices for brand-name prescription drugs increased an average of 8.7 percent, while generic drug prices decreased by nearly 11 percent, Merri Dee, president for AARP in Illinois, said. Prices of specialty prescription drugs, used to treat conditions that tend to affect older populations such as cancer and rheumatoid arthritis, increased by 9.3 percent" (7/13).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding access to GLP-1 weight-loss drugs could save thousands of lives